Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus

Journal of Molecular Biology

Volumn 315, Issue 4, 2002, Pages 873-885

  Bonaldo, Myrna C ^a   Garratt, Richard C ^b   Caufour, Philippe S ^a   Freire, Marcos S ^c   Rodrigues, Mauricio M ^d   Nussenzweig, Ruth S ^e   Galler, Ricardo ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Instituto de Technologia em Imunobiologicos   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

E protein structure; Foreign epitope expression; Malaria vaccine; Yellow fever 17D virus

Indexed keywords

ANTIGEN; DIMER; EPITOPE; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; B LYMPHOCYTE; CELL CULTURE; CONTROLLED STUDY; DIMERIZATION; DISEASE SEVERITY; ENDOSOME; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE INSERTION; MOUSE; NONHUMAN; PH; PHENOTYPE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; STEREOSPECIFICITY; TICK BORNE ENCEPHALITIS FLAVIVIRUS; VIROGENESIS; VIRUS GENOME; VIRUS RECOMBINANT; VIRUS REPLICATION; YELLOW FEVER FLAVIVIRUS;

ACARI; INSERTION SEQUENCES; PLASMODIUM FALCIPARUM; YELLOW FEVER VIRUS; YELLOW FEVER VIRUS (STRAIN 17D);

EID: 0036304601     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2001.5258     Document Type: Article

References (44)

1. Flavivirus genome organization, expression and evolution
2. Mutagenesis of N-linked glycosylation sites of the yellow fever virus NS1: Effects on virus replication and mouse neurovirulence
3. Genetic analysis of tellow fever virus NS1 protein: Identification of a temperature-sensitive mutation, which blocks RNA accumulation
4. The NS3 non-structural protein of flavivirus contains an RNA triphosphatase activity
5. Analysis of RNA-dependent RNA polymerase structure and function as guided by known polymerase structures and computer predictions of secondary structure
6. Evidence that the N-terminal domain of non-structural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein
7. Yellow fever/Japanese encephalitis chimeric viruses: Construction and biological properties
8. Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine:dose-response effectiveness and extended safety testing in rhesus monkeys
9. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates
10. Mutagenesis of the RGD motif in the yellow fever virus 17D envelope protein
11. Construction, characterization and immunogenicity in mice of recombinant yellow fever 17D-dengue type 2 viruses
12. Poliovirus type 1/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys
13. Immunogenicity and antigenicity of chimeric picornaviruses, which express hepatitis A virus (HAV) peptide sequences: Evidence for a neutralization domain near the amino terminus of VP1 of HAV
14. Infectious enveloped RNA virus antigenic chimeras
15. Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1
16. Display of epitopes on the suface of tobacco mosaic virus: Impact of charge and isoelectric point of the epitope on virus-host interactions
17. Genetic manipulation of equine arteritis virus using full-length cDNA clones: Separation of overlapping genes and expression of a foreign epitope
18. Recombinant yellow fever viruses are effective therapeutic vaccines for the treatment of murine experimental solid tumors and pulmonary metastases
19. Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1
20. Recombinant viruses expressing a human malaria antigen can elicit potentially protective immune CD8+ responses in mice
21. Recombinant Sindbis viruses expressing a cytotoxic T-lymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen in mice
22. The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution
23. Comparative model building by satisfaction of spatial restraints
24. Procheck - A program to check the stereochemical quality of protein structures
25. VERIFY3D: Assessment of protein models with three-dimensional profiles
26. Assessment of protein models with 3-dimensional profiles
27. WHAT IF - A molecular modeling and drug design program
28. Quality-control of protein models - Directional atomic contact analysis
29. Ligplot - A program to generate schematic diagrams of protein ligand interactions
30. Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes
31. Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax
32. Recombinant, chimeric live, attenuated vaccine (Chimerivax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in nonhuman primates
33. Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein
34. Flavivírus
35. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: Identification of na universal T cell epitope in the Plasmodium falciparum circumsporozoite protein
36. Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation
37. Nucleotide sequence of classical swine fever virus strain Alfort/187 and transcription of infectious RNA from stably cloned full-length cDNA
38. Heterogeneity in envelope protein sequence and N-linked glycosylation among yellow fever virus vaccine strains
39. The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites
40. Recent immunization against measles does not interfere with the sero-response to yellow fever vaccine
41. A strategy for the rapid multiple alignment of protein sequences - Confidence levels from tertiary structure comparisons
42. Calculation of protein conformations by proton proton distance constraints - A new efficient algorithm
43. Loops in globular-proteins - A novel category of secondary structure
44. Yellow Fever